TY - JOUR
T1 - Individual- And county-level determinants of high breast cancer incidence rates
AU - Schootman, Mario
AU - Ratnapradipa, Kendra
AU - Loux, Travis
AU - McVay, Allese
AU - Su, L. Joseph
AU - Nelson, Erik
AU - Kadlubar, Susan
N1 - Funding Information:
County-level breast cancer incidence data from 2008 to 2012 was obtained from the Arkansas Central Cancer Registry (ACCR). Specifically, the ACCR provided county-level age-adjusted breast cancer incidence rates for women diagnosed with ductal carcinoma in situ or invasive disease during 2008–2012. The ACCR is certified by the North American Association of Central Cancer Registries, and is a population-based registry financially supported by the Centers for Disease Control and Prevention (CDC) through their National Program of Cancer Registries and collects data on all cancers of Arkansas residents. Mandated reporters are required by Arkansas law (20-15-202) to
Publisher Copyright:
© Translational Cancer Research. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Background: Age-adjusted breast cancer rates vary across and within states. However, most statistical models inherently identify either individual- or area-level determinants to explain geographic disparities in breast cancer rates and ignore the effects of the other level of determinants. We present a micro-macro modelling approach that incorporates both levels of determinants to better explain this variability and to discover opportunities to reduce breast cancer rates. Methods: Individual-level data about breast cancer risk factors from eligible Arkansas Rural Community Health (ARCH) study participants (n=13,554) was supplemented with publicly available county-level data using a novel micro-macro statistical approach. This model uses individual-level data to account for aggregation-induced biases, to predict county-level breast cancer incidence rates across Arkansas. Results: County-level breast cancer incidence rates ranged from 80.9 to 161.6 per 100,000 population. The best-fit model, which included individual-level predicted risk based on the Gail/CARE models, county-level population density (log transformed), and lead exposure (log transformed), explained 14.1% of the county variance. Conclusions: Our results support theoretical models that maintain that area-level determinants of breast cancer incidence are key risk factors in addition to established individual risks.
AB - Background: Age-adjusted breast cancer rates vary across and within states. However, most statistical models inherently identify either individual- or area-level determinants to explain geographic disparities in breast cancer rates and ignore the effects of the other level of determinants. We present a micro-macro modelling approach that incorporates both levels of determinants to better explain this variability and to discover opportunities to reduce breast cancer rates. Methods: Individual-level data about breast cancer risk factors from eligible Arkansas Rural Community Health (ARCH) study participants (n=13,554) was supplemented with publicly available county-level data using a novel micro-macro statistical approach. This model uses individual-level data to account for aggregation-induced biases, to predict county-level breast cancer incidence rates across Arkansas. Results: County-level breast cancer incidence rates ranged from 80.9 to 161.6 per 100,000 population. The best-fit model, which included individual-level predicted risk based on the Gail/CARE models, county-level population density (log transformed), and lead exposure (log transformed), explained 14.1% of the county variance. Conclusions: Our results support theoretical models that maintain that area-level determinants of breast cancer incidence are key risk factors in addition to established individual risks.
KW - Breast neoplasms
KW - Geography
KW - Healthcare disparities
KW - Neighborhood
KW - Risk assessment
UR - http://www.scopus.com/inward/record.url?scp=85072306616&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072306616&partnerID=8YFLogxK
U2 - 10.21037/tcr.2019.06.08
DO - 10.21037/tcr.2019.06.08
M3 - Article
C2 - 35117111
AN - SCOPUS:85072306616
SN - 2218-676X
VL - 8
SP - S323-S333
JO - Translational Cancer Research
JF - Translational Cancer Research
ER -